NCT02529865View on ClinicalTrials.gov

Clinical Trial of Autologous Adipose Derived Regenerative Cells for the Treatment of Male Stress Urinary Incontinence

PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 29, 2015

Primary Completion Date

March 7, 2019

Study Completion Date

March 7, 2019

Conditions
Urinary Incontinence , Stress
Interventions
BIOLOGICAL

Periurethral injection of autologous ADRCs and adipose tissue

1 mL of the isolated ADRC is injected into the region of the external urethral sphincter, and another 4 mL of the ADRC and 16mL autologous adipose cells is injected under the urethral mucosa.

Trial Locations (4)

466-8560

Nagoya university Hospital, Nagoya

920-8641

Kanazawa University Hospital, Kanazawa

390-8621

Shinshu University Hospital, Matsumoto

321-0293

Dokkyo Medical University Hospital, Shimotsuga-gun

All Listed Sponsors
lead

Nagoya University

OTHER

NCT02529865 - Clinical Trial of Autologous Adipose Derived Regenerative Cells for the Treatment of Male Stress Urinary Incontinence | Biotech Hunter | Biotech Hunter